Stock Screener App

Frei -

Installieren

13.80

1.77% 0.24

after-market

Handel nachbörslich: 13.80

Janux Therapeutics Inc (JANX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Janux Therapeutics Inc-Aktie (JANX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	10.00	-	-	-
Operating Expenses	6.30% 42.40	45.25	-	-	29.02
Benefits Costs and Expenses	6.90% 31.95	34.31	-	-	20.22
Costs And Expenses	6.90% 31.95	34.31	-	-	20.22
Operating Income/Loss	20.28% -42.40	-35.25	-45.12	-34.90	-29.02
Nonoperating Income/Loss	4.42% 10.46	10.94	11.26	11.39	8.806
Income/Loss From Continuing Operations Before Tax	31.39% -31.95	-24.31	-33.86	-23.51	-20.22
Income/Loss From Continuing Operations After Tax	31.39% -31.95	-24.31	-33.86	-23.51	-20.22
Net Income/Loss	31.39% -31.95	-24.31	-33.86	-23.51	-20.22
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.90% 0.0602	62.02	61.90	61.79	1.0345
Diluted Average Shares	99.90% 0.0602	62.02	61.90	61.79	1.0345
Basic Earnings Per Share	30.77% -0.51	-0.39	-0.55	-0.38	-0.35
Diluted Earnings Per Share	30.77% -0.51	-0.39	-0.55	-0.38	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters